Gregory Kasper News Today

The Securities and Exchange Commission today filed a settled complaint charging Las Vegas-based nutritional supplement company MusclePharm Corp.s former Executive Vice President of Sales and Operations, Brian H. Casutto, former Vice President of Sales, ...

The Securities and Exchange Commission announced charges against Fernando Passos, the former executive vice president of finance and investor relations of Brazilian reinsurance company IRB Brasil Resseguros S.A., for allegedly planting a false story with the media and disseminating false documents claiming that Berkshire Hathaway Inc. had recently...

The Securities and Exchange Commission today announced charges against Fernando Passos, the former executive vice president of finance and investor relations of Brazilian reinsurance company IRB Brasil Resseguros S.A., for allegedly planting a false story with the media and disseminating false documents claiming that Berkshire Hathaway Inc. had...

<p><span>The Securities and Exchange Commission today announced charges against Fernando Passos, the former executive vice president of finance and investor relations of Brazilian reinsurance company IRB Brasil Resseguros S.A., for allegedly planting a false story with the media and disseminating false documents claiming that Berkshire Hathaway Inc. had recently made a substantial investment in IRB.</span></p>

SEC Charges Under Armour Inc. With Disclosure Failures Date 03/05/2021 The Securities and Exchange Commission today charged sports apparel manufacturer Under Armour Inc. with misleading investors as to the bases of its revenue growth and failing to disclose known uncertainties concerning its future revenue prospects. Under Armour has agreed to pay $9 million to settle the action. According to the SECs order, by the second half of 2015, Under Armours internal revenue and revenue growth for...

Litigation Release No. 24984 / December 15, 2020 Securities and Exchange Commission v. Roland M. Mathys, No. 18-civ-00701-JGK (S.D.N.Y.) On December 2, 2020, the U.S. District Court for the Southern District of New York entered a default judgment against Roland M. Mathys for insider trading in the securities of Bioverativ, Inc. The SECs complaint against Mathys, filed on June 13, 2019, alleged that Mathys received material non-public information about an impending acquisition of Bioverativ and,...